In an international project led by the Luxembourg Institute of Health, with the coorperation of the international research association, Cardiolink, researchers and doctors have identified a biomolecule which, according to its abundance in the blood, may help predict the risk of developing heart failure after a heart attack. Early detection may even help to prevent the onset of heart failure.
Cardiovascular disease is the leading cause of death in Luxembourg and Europe. If patients have survived a heart attack, some of them may still eventually develop heart failure that greatly shortens life expectancy.
The results of the study were recently published in the prestigious American scientific journal the Journal of the American College of Cardiology, under the title "Myocardial Infarction-Associated Circular RNA Predicting Left Ventricular Dysfunction."
